Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
Broadcom
AVGO
|
+$2.06B |
| 2 |
Nasdaq
NDAQ
|
+$1.76B |
| 3 |
Wells Fargo
WFC
|
+$1.1B |
| 4 |
Gilead Sciences
GILD
|
+$978M |
| 5 |
Edwards Lifesciences
EW
|
+$964M |
Top Sells
| 1 |
EOG Resources
EOG
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.75B |
| 3 |
HCA Healthcare
HCA
|
+$1.51B |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.48B |
| 5 |
PNC Financial Services
PNC
|
+$1.29B |
Sector Composition
| 1 | Technology | 23.24% |
| 2 | Healthcare | 19.6% |
| 3 | Financials | 13.95% |
| 4 | Consumer Discretionary | 9.41% |
| 5 | Industrials | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1451
CNA Financial
CNA
$12.8B
| $2.01M | ﹤0.01% |
41,051
+12,528
| +44% | +$613K |
|
1452
Fortis
FTS
$24.7B
| $1.99M | ﹤0.01% |
43,854
+6,779
| +18% | +$308K |
|
1453
Phibro Animal Health
PAHC
$1.67B
| $1.99M | ﹤0.01% |
88,343
-29,003
| -25% | -$653K |
|
1454
West Pharmaceutical
WST
$18.4B
| $1.97M | ﹤0.01% |
6,557
+799
| +14% | +$240K |
|
1455
Pure Storage
PSTG
$26.5B
| $1.97M | ﹤0.01% |
39,154
-2,336,275
| -98% | -$117M |
|
1456
GE HealthCare
GEHC
$34.7B
| $1.95M | ﹤0.01% |
20,766
-1,592
| -7% | -$149K |
|
1457
Chemed
CHE
$6.56B
| $1.95M | ﹤0.01% |
3,242
-65,275
| -95% | -$39.2M |
|
|
BBOT
1458
BridgeBio Oncology Therapeutics, Inc. Common Stock
BBOT
$797M
| $1.93M | ﹤0.01% |
184,670
| – | – |
|
1459
Madrigal Pharmaceuticals
MDGL
$9.58B
| $1.92M | ﹤0.01% |
+9,031
| New | +$1.92M |
|
1460
Arbutus Biopharma
ABUS
$886M
| $1.91M | ﹤0.01% |
496,818
+21,807
| +5% | +$84K |
|
1461
Air Products & Chemicals
APD
$64B
| $1.91M | ﹤0.01% |
6,423
-6,955
| -52% | -$2.07M |
|
1462
NewtekOne
NEWT
$304M
| $1.9M | ﹤0.01% |
+152,638
| New | +$1.9M |
|
1463
Corcept Therapeutics
CORT
$7.54B
| $1.9M | ﹤0.01% |
41,066
-4,195
| -9% | -$194K |
|
1464
Cardinal Health
CAH
$35.7B
| $1.9M | ﹤0.01% |
17,148
-1,522
| -8% | -$168K |
|
1465
Keysight
KEYS
$29.3B
| $1.88M | ﹤0.01% |
11,811
+587
| +5% | +$93.3K |
|
1466
MiMedx Group
MDXG
$1.02B
| $1.88M | ﹤0.01% |
317,274
+33,461
| +12% | +$198K |
|
1467
Vanguard Mid-Cap Value ETF
VOE
$18.7B
| $1.86M | ﹤0.01% |
11,112
| – | – |
|
1468
Nutanix
NTNX
$20.7B
| $1.86M | ﹤0.01% |
31,405
-4,319
| -12% | -$256K |
|
1469
NetApp
NTAP
$24.7B
| $1.85M | ﹤0.01% |
14,998
-3,934
| -21% | -$486K |
|
1470
Terns Pharmaceuticals
TERN
$655M
| $1.85M | ﹤0.01% |
222,065
-2,111
| -0.9% | -$17.6K |
|
1471
Southern First Bancshares
SFST
$362M
| $1.84M | ﹤0.01% |
53,903
-35,033
| -39% | -$1.19M |
|
1472
Invitation Homes
INVH
$18.4B
| $1.83M | ﹤0.01% |
51,908
+2,877
| +6% | +$101K |
|
1473
Liquidia Corp
LQDA
$2.35B
| $1.8M | ﹤0.01% |
179,923
+19,932
| +12% | +$199K |
|
1474
Y-mAbs Therapeutics
YMAB
$389M
| $1.8M | ﹤0.01% |
136,714
-23,730
| -15% | -$312K |
|
1475
4D Molecular Therapeutics
FDMT
$325M
| $1.8M | ﹤0.01% |
166,190
-13,254
| -7% | -$143K |
|